The human Gateway® entry clones used in the iPS cell research
Dr. Momoko. Maekawa and Dr. Shinya. Yamanaka of Kyoto University, Dr. Naoki. Goshima of National Institute of Advanced Industrial Science and Technology, and their colleagues have published the results of their joint research about the generation of iPS cells on June 9th issue of Nature.
The following human Gateway® entry clones containing transcription factor Glis1 gene, used in the above iPS cell research are available from NBRC.
Click here for more information about human Gateway® entry clones and order.
*Gateway® is a registered trademark of Invitrogen.
- Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, Ichisaka T, Kawamura Y, Mochizuki H, Goshima N, Yamanaka S. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1.
Nature 2011 Jun 8;474(7350):225-9. doi: 10.1038/nature10106. [PubMed: 21654807]